UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diastolic Function in Systemic Sclerosis Patients: A Neglected Issue?

Journal of the American College of Cardiology, 2018-10, Vol.72 (15), p.1814-1816

2018

Volltextzugriff (PDF)

Sex‐related differential susceptibility to ponatinib cardiotoxicity and differential modulation of the Notch1 signalling pathway in a murine model

Journal of cellular and molecular medicine, 2022-03, Vol.26 (5), p.1380-1391

2022

Volltextzugriff (PDF)

Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens

Heart failure reviews, 2019-11, Vol.24 (6), p.915-925

2019

Volltextzugriff (PDF)

Metabolomic Perspectives in Antiblastic Cardiotoxicity and Cardioprotection

International journal of molecular sciences, 2019-10, Vol.20 (19), p.4928

2019

Volltextzugriff (PDF)

Metabolomic fingerprint of coronary blood in STEMI patients depends on the ischemic time and inflammatory state

Scientific reports, 2019-01, Vol.9 (1), p.312-312, Article 312

2019

Volltextzugriff (PDF)

Blood metabolomic fingerprint is distinct in healthy coronary and in stenosing or microvascular ischemic heart disease

Journal of translational medicine, 2017-05, Vol.15 (1), p.112-112, Article 112

2017

Volltextzugriff (PDF)

Atrial Strain Assessment for the Early Detection of Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer Women (The STRANO STUDY: Atrial Strain in Cardio-Oncology)

Journal of clinical medicine, 2023-11, Vol.12 (22), p.7127

2023

Volltextzugriff (PDF)

Metabolomic Profiles on Antiblastic Cardiotoxicity: New Perspectives for Early Diagnosis and Cardioprotection

Journal of clinical medicine, 2022-11, Vol.11 (22), p.6745

2022

Volltextzugriff (PDF)

Metabolomic Approach to Redox and Nitrosative Reactions in Cardiovascular Diseases

Frontiers in physiology, 2018-06, Vol.9, p.672-672

2018

Volltextzugriff (PDF)

Addressing Post-Acute COVID-19 Syndrome in Cancer Patients, from Visceral Obesity and Myosteatosis to Systemic Inflammation: Implications in Cardio-Onco-Metabolism

Biomedicines, 2024-07, Vol.12 (8), p.1650

2024

Volltextzugriff (PDF)

Right Ventricular Subclinical Dysfunction in SLE Patients Correlates with Metabolomic Fingerprint and Organ Damage

Metabolites, 2023-06, Vol.13 (7), p.781

2023

Volltextzugriff (PDF)

Redox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC)

Antioxidants, 2020-07, Vol.9 (7), p.641

2020

Volltextzugriff (PDF)

Why Do High-Risk Patients Develop or Not Develop Coronary Artery Disease? Metabolic Insights from the CAPIRE Study

Metabolites, 2022-01, Vol.12 (2), p.123

2022

Volltextzugriff (PDF)

Diastolic Function in Systemic Sclerosis Patients

Journal of the American College of Cardiology, 2018-10, Vol.72 (15), p.1814-1816

2018

Volltextzugriff (PDF)

Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors

Journal of clinical medicine, 2020-04, Vol.9 (4), p.1180

2020

Volltextzugriff (PDF)

Feasibility of cardiopulmonary exercise test in an athlete who underwent total laringectomy

The Journal of Sports Medicine and Physical Fitness, 2024-09

2024

Volltextzugriff (PDF)

Antioxidant Approach as a Cardioprotective Strategy in Chemotherapy-Induced Cardiotoxicity

Antioxidants & redox signaling, 2021-03, Vol.34 (7), p.572-588

2021

Volltextzugriff (PDF)

Early ischemia identification employing 2D speckle tracking selective layers analysis during dobutamine stress echocardiography

Echocardiography (Mount Kisco, N.Y.), 2019-12, Vol.36 (12), p.2202-2208

2019

Volltextzugriff (PDF)

Metabolomic approach to profile functional and metabolic changes in heart failure

Journal of translational medicine, 2015-09, Vol.13 (1), p.297-297, Article 297

2015

Volltextzugriff (PDF)

Potential cardiac risk of immune‐checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects

Medicinal research reviews, 2018-09, Vol.38 (5), p.1447-1468

2018

Volltextzugriff (PDF)

Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answers

Current problems in cardiology, 2024-03, Vol.49 (3), p.102229-102229, Article 102229

2024

Volltextzugriff (PDF)

Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension

International journal of cardiology, 2017-08, Vol.241, p.401-406

2017

Volltextzugriff (PDF)

Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC)

European heart journal cardiovascular imaging, 2021-03, Vol.22 (4), p.406-415

2021

Volltextzugriff (PDF)

Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention

Journal of cardiovascular medicine (Hagerstown, Md.), 2018-07, Vol.19 (7), p.315-323

2018

Volltextzugriff (PDF)

Metabolomics, a promising approach to translational research in cardiology

IJC metabolic & endocrine, 2015-12, Vol.9, p.31-38

2015

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Englisch
(53)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Diastolic Function in Systemic Sclerosis Patients: A Neglected Issue?

Sex‐related differential susceptibility to ponatinib cardiotoxicity and differential modulation of the Notch1 signalling pathway in a murine model

Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens

Metabolomic Perspectives in Antiblastic Cardiotoxicity and Cardioprotection

Metabolomic fingerprint of coronary blood in STEMI patients depends on the ischemic time and inflammatory state

Blood metabolomic fingerprint is distinct in healthy coronary and in stenosing or microvascular ischemic heart disease

Atrial Strain Assessment for the Early Detection of Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer Women (The STRANO STUDY: Atrial Strain in Cardio-Oncology)

Metabolomic Profiles on Antiblastic Cardiotoxicity: New Perspectives for Early Diagnosis and Cardioprotection

Metabolomic Approach to Redox and Nitrosative Reactions in Cardiovascular Diseases

Addressing Post-Acute COVID-19 Syndrome in Cancer Patients, from Visceral Obesity and Myosteatosis to Systemic Inflammation: Implications in Cardio-Onco-Metabolism

Right Ventricular Subclinical Dysfunction in SLE Patients Correlates with Metabolomic Fingerprint and Organ Damage

Redox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC)

Why Do High-Risk Patients Develop or Not Develop Coronary Artery Disease? Metabolic Insights from the CAPIRE Study

Diastolic Function in Systemic Sclerosis Patients

Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors

Feasibility of cardiopulmonary exercise test in an athlete who underwent total laringectomy

Antioxidant Approach as a Cardioprotective Strategy in Chemotherapy-Induced Cardiotoxicity

Early ischemia identification employing 2D speckle tracking selective layers analysis during dobutamine stress echocardiography

Metabolomic approach to profile functional and metabolic changes in heart failure

Potential cardiac risk of immune‐checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects

Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answers

Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension

Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC)

Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention

Metabolomics, a promising approach to translational research in cardiology

Suchergebnisse filtern